2015
New targets to treat obesity and the metabolic syndrome
Martin KA, Mani MV, Mani A. New targets to treat obesity and the metabolic syndrome. European Journal Of Pharmacology 2015, 763: 64-74. PMID: 26001373, PMCID: PMC4573317, DOI: 10.1016/j.ejphar.2015.03.093.Peer-Reviewed Original ResearchConceptsMetabolic syndromeCardiovascular diseaseGlucagon-like peptide-1 receptor agonistsPancreatic lipase inhibitor orlistatSingle CVD risk factorPeptide-1 receptor agonistsCVD risk factorsEpidemic of obesityLong-term treatmentType 2 diabetesLipase inhibitor orlistatDipeptidyl peptidase IV inhibitorsAnti-diabetic drugsFuture drug developmentTruncal obesitySerotonergic drugsReceptor agonistRisk factorsMelanocortin systemObesityMetabolic traitsSyndromeMetabolic profileIV inhibitorsNew targets
2012
Prevalence of Obesity and Traditional Cardiovascular Risk Factors in South Asians
Khanna P, Mani A. Prevalence of Obesity and Traditional Cardiovascular Risk Factors in South Asians. Current Cardiovascular Risk Reports 2012, 6: 112-119. DOI: 10.1007/s12170-012-0220-x.Peer-Reviewed Original ResearchRisk factorsCardiovascular diseaseSouth AsiansTraditional cardiovascular risk factorsCardiovascular risk factorsCVD risk factorsPrevalence of obesityLifestyle factorsNovel biomarkersGenetic predispositionHealthcare providersDisease controlNovel therapeuticsMajor causeGenetic causePrevalenceObesityWestern worldAsiansCauseImportant contributorDiabetesSpecific differencesFactorsMortality